Telmisartan has antioxidative effects in healthy dogs

Area of Science:

• Veterinary Pharmacology
• Canine Health
• Oxidative Stress Research

Background:

• Telmisartan is an angiotensin II receptor blocker with known anti-inflammatory and antioxidant properties.
• Its effects on oxidative stress markers in healthy dogs are not well-established.
• Understanding these effects can inform potential therapeutic applications in veterinary medicine.

Purpose of the Study:

• To investigate the immunomodulatory and antioxidative effects of telmisartan in healthy dogs.
• To assess changes in antioxidant enzyme activity and inflammatory markers following telmisartan administration.

Main Methods:

• Eight healthy Beagles received daily oral telmisartan (10 mg) for 28 days.
• Weekly assessments included a complete blood count (CBC), serum cytokine/chemokine analysis, and antioxidant assays (total antioxidant capacity, superoxide dismutase, catalase, glutathione reductase, glutathione peroxidase).
• Statistical analysis involved repeated-measures ANOVA comparing post-treatment values to baseline.

Main Results:

• Telmisartan significantly increased serum superoxide dismutase, total antioxidant capacity, and plasma glutathione peroxidase activity on certain days.
• No significant changes were observed in CBC, arterial blood pressure, or cytokine/chemokine levels.
• A mean weight loss of 4.9% was noted in 7 out of 8 dogs over the 28-day period.

Conclusions:

• Telmisartan exhibits notable antioxidative effects in healthy dogs.
• The drug upregulated specific antioxidant enzymes, indicating a potential role in managing conditions associated with oxidative stress.